BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 29061818)

  • 1. The Synthetic Cannabinoid WIN 55,212-2 Elicits Death in Human Cancer Cell Lines.
    Müller L; Radtke A; Decker J; Koch M; Belge G
    Anticancer Res; 2017 Nov; 37(11):6341-6345. PubMed ID: 29061818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis induced in HepG2 cells by the synthetic cannabinoid WIN: involvement of the transcription factor PPARgamma.
    Giuliano M; Pellerito O; Portanova P; Calvaruso G; Santulli A; De Blasio A; Vento R; Tesoriere G
    Biochimie; 2009 Apr; 91(4):457-65. PubMed ID: 19059457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid WIN 55,212-2 induces cell cycle arrest and apoptosis, and inhibits proliferation, migration, invasion, and tumor growth in prostate cancer in a cannabinoid-receptor 2 dependent manner.
    Roberto D; Klotz LH; Venkateswaran V
    Prostate; 2019 Feb; 79(2):151-159. PubMed ID: 30242861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CB1/CB2 receptor agonist WIN-55,212-2 reduces viability of human Kaposi's sarcoma cells in vitro.
    Luca T; Di Benedetto G; Scuderi MR; Palumbo M; Clementi S; Bernardini R; Cantarella G
    Eur J Pharmacol; 2009 Aug; 616(1-3):16-21. PubMed ID: 19539619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the CB
    Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C
    BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WIN induces apoptotic cell death in human colon cancer cells through a block of autophagic flux dependent on PPARγ down-regulation.
    Pellerito O; Notaro A; Sabella S; De Blasio A; Vento R; Calvaruso G; Giuliano M
    Apoptosis; 2014 Jun; 19(6):1029-42. PubMed ID: 24696378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid receptor agonist as an alternative drug in 5-fluorouracil-resistant gastric cancer cells.
    Xian XS; Park H; Choi MG; Park JM
    Anticancer Res; 2013 Jun; 33(6):2541-7. PubMed ID: 23749906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The synthetic cannabinoid WIN 55,212-2 sensitizes hepatocellular carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by activating p8/CCAAT/enhancer binding protein homologous protein (CHOP)/death receptor 5 (DR5) axis.
    Pellerito O; Calvaruso G; Portanova P; De Blasio A; Santulli A; Vento R; Tesoriere G; Giuliano M
    Mol Pharmacol; 2010 May; 77(5):854-63. PubMed ID: 20159939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPARγ mediates the effects of WIN55,212-2, an synthetic cannabinoid, on the proliferation and apoptosis of the BEL-7402 hepatocarcinoma cells.
    Hong Y; Zhou Y; Wang Y; Xiao S; Liao DJ; Zhao Q
    Mol Biol Rep; 2013 Nov; 40(11):6287-93. PubMed ID: 24062073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The synthetic cannabinoid WIN-55,212 induced-apoptosis in cytotrophoblasts cells by a mechanism dependent on CB1 receptor.
    Almada M; Costa L; Fonseca BM; Amaral C; Teixeira N; Correia-da-Silva G
    Toxicology; 2017 Jun; 385():67-73. PubMed ID: 28495606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Cannabidiol, ∆9-Tetrahydrocannabinol, and WIN 55-212-22 on the Viability of Canine and Human Non-Hodgkin Lymphoma Cell Lines.
    Omer S; Pathak S; Mansour M; Nadar R; Bowen D; Dhanasekaran M; Pondugula SR; Boothe D
    Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. R-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)-pyrrolo-[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphtalenylmethanone (WIN-2) ameliorates experimental autoimmune encephalomyelitis and induces encephalitogenic T cell apoptosis: partial involvement of the CB(2) receptor.
    Sánchez AJ; González-Pérez P; Galve-Roperh I; García-Merino A
    Biochem Pharmacol; 2006 Dec; 72(12):1697-706. PubMed ID: 17007821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a synthetic cannabinoid agonist on the proliferation and invasion of gastric cancer cells.
    Xian XS; Park H; Cho YK; Lee IS; Kim SW; Choi MG; Chung IS; Han KH; Park JM
    J Cell Biochem; 2010 May; 110(2):321-32. PubMed ID: 20336665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antineoplastic effect of WIN 55,212-2, a cannabinoid agonist, in a murine xenograft model of gastric cancer.
    Oh JH; Lee JY; Baeg MK; Han KH; Choi MG; Park JM
    Chemotherapy; 2013; 59(3):200-6. PubMed ID: 24335109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antimitogenic effect of the cannabinoid receptor agonist WIN55212-2 on human melanoma cells is mediated by the membrane lipid raft.
    Scuderi MR; Cantarella G; Scollo M; Lempereur L; Palumbo M; Saccani-Jotti G; Bernardini R
    Cancer Lett; 2011 Nov; 310(2):240-9. PubMed ID: 21807457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WIN 55,212-2, agonist of cannabinoid receptors, prevents amyloid β1-42 effects on astrocytes in primary culture.
    Aguirre-Rueda D; Guerra-Ojeda S; Aldasoro M; Iradi A; Obrador E; Mauricio MD; Vila JM; Marchio P; Valles SL
    PLoS One; 2015; 10(4):e0122843. PubMed ID: 25874692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiproliferative mechanism of a cannabinoid agonist by cell cycle arrest in human gastric cancer cells.
    Park JM; Xian XS; Choi MG; Park H; Cho YK; Lee IS; Kim SW; Chung IS
    J Cell Biochem; 2011 Apr; 112(4):1192-205. PubMed ID: 21312237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cannabinoid WIN 55,212-2-mediated protection of dentate gyrus granule cells is driven by CB1 receptors and modulated by TRPA1 and Cav 2.2 channels.
    Koch M; Kreutz S; Böttger C; Grabiec U; Ghadban C; Korf HW; Dehghani F
    Hippocampus; 2011 May; 21(5):554-64. PubMed ID: 20135626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of PAR-4 in cannabinoid-dependent sensitization of osteosarcoma cells to TRAIL-induced apoptosis.
    Notaro A; Sabella S; Pellerito O; Di Fiore R; De Blasio A; Vento R; Calvaruso G; Giuliano M
    Int J Biol Sci; 2014; 10(5):466-78. PubMed ID: 24795528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the effects of CP 55-940 and other cannabinoid receptor agonists in C6 and U373 cell lines.
    Ortega A; Rangel-López E; Hidalgo-Miranda A; Morales A; Ruiz-García E; Meneses-García A; Herrera-Gómez A; Aguilar-Ponce JL; González-Herrera IG; Guevara-Salazar P; Prospero-García O; Del Angel SA
    Toxicol In Vitro; 2015 Oct; 29(7):1941-51. PubMed ID: 26255146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.